Inventor profile of:

Bin Wang

City:

Newton, Massachusetts

Country:

United States

Published Applications:

20

Last publication date:

2025-12-11

Top Assignees for applications by Bin Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Bin:

Recent patent applications by Wang Bin

Bin Wang from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-11
US20250376452A1
Chemistry; metallurgy

17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof

#2 | 2025-05-15
US20250154163A1
Chemistry; metallurgy

Pyrimidinone-Containing 17-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors

#3 | 2024-11-14
US20240376079A1
Chemistry; metallurgy

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof

#4 | 2024-11-07
US20240368096A1
Chemistry; metallurgy

Fused Heterobicyclic Antiviral Agents

#5 | 2024-10-03
US20240327334A1
Chemistry; metallurgy

Covalent Inhibitors As Antiviral Agents

#6 | 2024-07-11
US20240228464A9
Chemistry; metallurgy

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF

#7 | 2024-06-27
US20240207224A1
Human necessities

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

#8 | 2024-05-02
US20240140922A1
Chemistry; metallurgy

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

#9 | 2024-04-25
US20240132476A1
Chemistry; metallurgy

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF

#10 | 2023-12-28
US20230416268A1
Chemistry; metallurgy

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS

#11 | 2023-06-08
US20230174515A1
Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#12 | 2023-05-11
US20230143250A1
Chemistry; metallurgy

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF

#13 | 2022-11-10
US20220356167A1
Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#14 | 2022-04-21
US20220119366A1
Chemistry; metallurgy

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#15 | 2020-11-19
US20200361920A1
Chemistry; metallurgy

Isoxazole derivatives as FXR agonists and methods of use thereof

#16 | 2020-10-22
US20200331890A1
Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#17 | 2020-08-27
US20200270303A1
Chemistry; metallurgy

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

#18 | 2020-08-06
US20200247839A1
Chemistry; metallurgy

Process for preparation of sulfonylurea bile acid derivatives

#19 | 2020-05-21
US20200157095A1
Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#20 | 2020-03-12
US20200079764A1
Chemistry; metallurgy

Isoxazole analogs as FXR agonists and methods of use thereof

InventorID:

2669837 ⎘